Download What`s New in Sports Nutrition?

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

DNA vaccination wikipedia , lookup

Urinary tract infection wikipedia , lookup

Neonatal infection wikipedia , lookup

Complement system wikipedia , lookup

Childhood immunizations in the United States wikipedia , lookup

Immunocontraception wikipedia , lookup

Herd immunity wikipedia , lookup

Adaptive immune system wikipedia , lookup

Polyclonal B cell response wikipedia , lookup

Myasthenia gravis wikipedia , lookup

Sociality and disease transmission wikipedia , lookup

Sjögren syndrome wikipedia , lookup

Chickenpox wikipedia , lookup

Immune system wikipedia , lookup

Common cold wikipedia , lookup

Social immunity wikipedia , lookup

Cancer immunotherapy wikipedia , lookup

Innate immune system wikipedia , lookup

Immunosuppressive drug wikipedia , lookup

Immunomics wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Psychoneuroimmunology wikipedia , lookup

Transcript
What’s New in Sports Nutrition?
Powering the Immune System to
Power Athletic Performance
Why Immune Support for Athletes?
Staying healthy is critical to effective training. Protein and recovery products have long
dominated the sports nutrition field to help rebuild muscle and replace nutrients. Often
overlooked is the contribution that boosting immunity can make to athletic performance.
And, there’s a growing body of clinical evidence to support including dietary interventions
to support immune health on the training table. Whether you’re counseling a competitive
or recreational athlete, stronger immunity can help keep them going strong.
Immune health is of particular importance to athletes because high-intensity exercise
temporarily weakens the immune system1. It can create an “open window” in the body’s
defenses that may derail training programs and performance gains. Upper respiratory
tract infection symptoms commonly afflict distance runners and other athletes.
The challenge to scientists was in finding a dietary solution that athletes could use daily
to be well—whether during periods of intensive training, in the heat of competition and
even during the off season.
The novel solution: harnessing the body’s natural defenses to safely prime immune cells
that keep the body healthy, with a proprietary beta 1,3/1,6 glucan called Wellmune WGP®.
Wellmune WGP® is a natural
immune health ingredient in
more than 100 foods, beverages
and supplements in over 50
countries. It is derived from a
proprietary strain of baker’s
yeast. Wellmune activates
billions of innate immune cells
to respond more effectively
without stimulating the
immune system.2
Why Wellmune?
Nine human clinical studies3 with marathoners, cyclists and others enduring high physical
and lifestyle stress demonstrate how Wellmune can strengthen immune defenses before,
during and after exercise.
Wellmune reduces the incidence of upper respiratory tract infection
symptoms. In multiple clinical studies Wellmune reduced the incidence of symptoms
that commonly afflict distance runners and other athletes. In a double-blinded study
involving 182 runners who completed a 2011 marathon (figure 1), subjects taking
Wellmune for four weeks experienced a 40% reduction in URTI symptoms.
Wellmune also enhances vigor and mental clarity while reducing
fatigue. In physical stress studies with marathoners (figure 2) and others, those taking
Wellmune benefited psychologically based on a Profile of Mood States (POMS)
psychometric test that measures six primary mood states: tension, depression, anger,
fatigue, vigor and confusion.
May be reproduced for educational purposes.
The mechanism of action of Wellmune is well understood and biomarker
data supports athletic performance benefits. Clinical research involving high
intensity exercise conducted at the University of Houston showed statistically significant
improvement in biomarkers for athletes taking Wellmune before and after working out.
Wellmune is safe for daily use and compliant with anti-doping requirements.
Wellmune is generally recognized as safe (GRAS) in accordance with U.S. FDA regulations
and has been tested by the world-class sports anti-doping lab, HFL Sport Science.
2011 Texas Marathon
Wellmune Reduced URTI Symptoms an Average of 40% vs Control
Figure 1: Research presented at the 2012 American College of Sports Medicine. Accepted for
publication by the Journal of Dietary Supplements, 2013.
27
14
25
13
11
*
10
Baseline
Week 2
Week 4
POMS Score
POMS Score
15
12
8
23
Baseline
Week 2
Week 4
21
19
15
Placebo
250mg Wellmune WGP
Placebo
20
14
*
12
10
Baseline
Week 2
Week 4
8
Placebo
250mg Wellmune WGP
POMS Score
16
12
11
*
10
Baseline
Week 2
Week 4
9
8
Placebo
• Immune system refresher
• Perspectives from our sports dietitian scientific advisors
13
18
• Abstracts and clinical
research insights
• FREE continuing education modules eligible for CPEU
250mg Wellmune WGP
POMS Confusion Factor
POMS Fatigue Factor
POMS Score
*
17
9
6
Learn more at
Wellmune.com
POMS Vigor Factor
POMS Tension Factor
250mg Wellmune WGP
Figure 2: “Effect of Beta 1,3/1,6 Glucan on Upper Respiratory Tract Infection Symptoms and Mood State in
Marathon Athletes.” Journal of Sports Science and Medicine (2009). 8:509-515.
References:
1Nieman DC, Berk LS, Simpson-Westerberg M, Arabatzis K,Youngberg S, Tan SA, et al. Effects of long-endurance running on immune system parameters
and lymphocyte function in experienced marathoners. Intl J Sports Med. 1989; 10(5):317-23.
2Hong F, Yan J, Baran JT, et al. (2004) Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor
monoclonal antibodies in murine tumor models. J Immunol. 173, 797-806.
3Carpenter et al. 2012. Brit. J Nutr.
on CJO 2012; Feldman et al. 2009. J. Appl. Res., 9:20-42; Fuller et al. 2012. Nutrition 28: 665-669; Talbott & Talbott, 2009.
J. Sports Sci. and Med. 8:509-515; Talbott, & Talbott 2010. Agro Food Industry Hi-Tech 21:21-24; Talbott & Talbott, 2013. J. Food & Nutr.; Talbott et. al., accepted
2013. J Am. Col. Nutr.; Ruby et al. presented at ACSM 2008, manuscript in development; McFarlin et. al., presented at ACSM 2012, manuscript in review.
May be reproduced for educational purposes.
• Product applications and technical specifications